Corneal specialists Thomas Steinemann, MD, of MetroHealth Medical Center and Ann P. Murchison, MD, MPH, of the Wills Eye Hospital, share tales of Halloween costume contact lens horrors bound to keep ophthalmologists up at night.
The study shows the therapy can have a clinically meaningful effect on outcomes, even for patients who have no radiographically significant decrease in tumor size.
A study shows that trauma is four to five times more likely to induce an inflammatory spared eye injury than vitrectomy.
Although case reports show some deleterious changes, a causal relationship is not yet established.
Recurrence dropped dramatically from 115 per 100 patients each year to before the start of SB5 to 3 relapses per 100 patients each year with the treatment.
Patients with uveitis of an infectious etiology also experienced more detachment.
SS-OCT shows a connecting channel between the premacular bursa and Cloquet’s canal.
Researchers offer a new set of diagnostic protocols for the commonly misdiagnosed condition.
The treatment resolved anterior chamber nodules in most patients, and the response was maintained throughout the follow-up period, a report shows.
Ocular inflammation occurring at the same time as swelling of black body art may point to tattoo-associated uveitis.
The technology can provide both absorption and scattering imaging contrasts, a study shows.
Study demonstrates the impact of lifestyle factors on the inflammatory condition.
A study shows the procedure can also help manage uveitic glaucoma.
Researchers assess possible correlation between the visual field and electroretinogram parameters in birdshot chorioretinopathy.
The algorithm demonstrated “excellent” agreement with the human graders in most instances.
Physicians should monitor for flares after switching, especially within the first 90 days.
The study advocates for close collaboration between uveitis and glaucoma specialists.
Researchers compared 10 years of clinical outcomes for the Boston Keratoprosthesis type 1.
A case report reviews a 71-year-old patient who presented with blurry vision 2 weeks after starting a lung cancer treatment.
A trial evaluated changes in health-related and vision-related quality of life among those who received the treatment.